Cargando…

Visceral Adiposity Index as a Measure of Cardiovascular Disease in Persons With Human Immunodeficiency Virus

BACKGROUND: Persons with well-treated human immunodeficiency virus (HIV) demonstrate a 2-fold higher risk of cardiovascular disease (CVD), which may be related to excess visceral adipose tissue (VAT). The visceral adiposity index (VAI) is a score to approximate VAT by combining biochemical measures...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Teressa S, Dunderdale, Carolyn, Lu, Michael T, Walpert, Allie R, Shen, Grace, Young, Michele C H, Torriani, Martin, Chu, Jacqueline T, Haptu, Hanna H, Manandhar, Monica, Wurcel, Alysse, Adler, Gail K, Grinspoon, Steven K, Srinivasa, Suman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407462/ https://www.ncbi.nlm.nih.gov/pubmed/37559752 http://dx.doi.org/10.1093/ofid/ofad398

Ejemplares similares

RF12 | PSUN104 Visceral adiposity index as a measure of cardiometabolic disease in persons living with HIV
por: Thomas, Teressa Sumy, et al.
Publicado: (2022)

Primary Aldosteronism and COVID-19-related Management, Disease Severity, and Outcomes: A Retrospective Cohort Study
por: Thomas, Teressa S, et al.
Publicado: (2023)

Evaluation of Mineralocorticoid Receptor Antagonism on Changes in NT-proBNP Among Persons With HIV
por: Srinivasa, Suman, et al.
Publicado: (2021)

Hepatitis C Screening in People With Human Immunodeficiency Virus: Lessons Learned From Syphilis Screening
por: Wurcel, Alysse G., et al.
Publicado: (2016)

OR02-5 Coronary Microvascular Dysfunction is Present Among Well-Treated Asymptomatic Persons with HIV, Similar to Those with Diabetes
por: DiCarli, Marcelo, et al.
Publicado: (2022)

Aspartame Intake Relates to Coronary Plaque Burden and Inflammatory Indices in Human Immunodeficiency Virus
por: Hall, Leangelo N., et al.
Publicado: (2017)

“They Just Assume That We’re All Going to Do the Wrong Thing With It. It’s Just Not True”: Stakeholder Perspectives About Peripherally Inserted Central Catheters in People Who Inject Drugs
por: Morales, Yoelkys, et al.
Publicado: (2022)

Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients
por: Suchindran, Sujit, et al.
Publicado: (2014)

“To Be Honest, You Probably Would Have to Read It 50 Times”: Stakeholders Views on Using the Opt-Out Approach for Vaccination in Jails
por: Lodolo, Laura, et al.
Publicado: (2023)

Altered pattern of circulating miRNAs in HIV lipodystrophy perturbs key adipose differentiation and inflammation pathways
por: Srinivasa, Suman, et al.
Publicado: (2021)

MON-100 Unique miRNA Signature in HIV Lipodystrophy with Reduced Adipose Dicer Expression
por: Srinivasa, Suman, et al.
Publicado: (2019)

Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?
por: van Griensven, Johan, et al.
Publicado: (2018)

Impact of the American College of Cardiology/American Heart Association Cholesterol Guidelines on Statin Eligibility Among Human Immunodeficiency Virus-Infected Individuals
por: Mosepele, Mosepele, et al.
Publicado: (2018)

High-Density Lipoprotein-Mediated Cholesterol Efflux Capacity Is Improved by Treatment With Antiretroviral Therapy in Acute Human Immunodeficiency Virus Infection
por: Lo, Janet, et al.
Publicado: (2014)

Epidemiological profile and lethality of visceral leishmaniasis/human immunodeficiency virus co-infection in an endemic area in Northeast Brazil
por: Machado, Carolina Angélica Libório, et al.
Publicado: (2021)

“Tweak Your Order Set!” Implementation of Modified Laboratory Order Set Improves Hepatitis C Virus Screening Rates in People Living With Human Immunodeficiency Virus
por: Wurcel, Alysse G., et al.
Publicado: (2017)

Differential Levels of Soluble Inflammatory Markers by Human Immunodeficiency Virus Controller Status and Demographics
por: Li, Jonathan Z., et al.
Publicado: (2014)

Significant Association of Aldosterone and Liver Fat Among HIV-Infected Individuals With Metabolic Dysregulation
por: Srinivasa, Suman, et al.
Publicado: (2018)

The Impact of Direct-Acting Antivirals in the Hepatitis C-Sustained Viral Response in Human Immunodeficiency Virus-Infected Patients With Ongoing Barriers to Care
por: Cachay, Edward R., et al.
Publicado: (2015)

Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk Prediction
por: Goehler, Alexander, et al.
Publicado: (2021)

1937. COVID-19 Vaccine Distribution in Massachusetts Jails
por: Cassarino, Nicole, et al.
Publicado: (2022)

1499. Tesamorelin Reduces Visceral Adipose Tissue and Liver Fat in INSTI-Treated Persons with HIV
por: McLaughlin, Taryn, et al.
Publicado: (2023)

AmBisome Monotherapy and Combination AmBisome–Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial( )
por: Burza, Sakib, et al.
Publicado: (2022)

Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States
por: Zanni, Markella V, et al.
Publicado: (2022)

Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus
por: Cachay, Edward R, et al.
Publicado: (2019)

Every Minute Counts—The Time Is Now to Understand Predictors of Stroke in HIV
por: Srinivasa, Suman, et al.
Publicado: (2019)

Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus
por: Kileel, Emma M, et al.
Publicado: (2021)

Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection
por: El Kamari, Vanessa, et al.
Publicado: (2021)

Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus
por: Schnittman, Samuel R, et al.
Publicado: (2023)

Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis
por: Fulcher, Jennifer A, et al.
Publicado: (2019)

Visceral Leishmaniasis in Bolivia: Current Status
por: Mollinedo, Juan Sergio, et al.
Publicado: (2020)

FCGR2A and FCGR3A Genotypes in Human Immunodeficiency Virus Mother-to-Child Transmission
por: Milligan, Caitlin, et al.
Publicado: (2015)

Serum Albumin Is Associated With Higher Inflammation and Carotid Atherosclerosis in Treated Human Immunodeficiency Virus Infection
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2018)

Lung Function in Women With and Without Human Immunodeficiency Virus
por: Wang, Richard J, et al.
Publicado: (2022)

Acceptability and Feasibility of a Pharmacist-Led Human Immunodeficiency Virus Pre-Exposure Prophylaxis Program in the Midwestern United States
por: Havens, Joshua P, et al.
Publicado: (2019)

Antiretroviral Refill Histories as a Predictor of Future Human Immunodeficiency Virus Viremia
por: Sokpa, Darryl, et al.
Publicado: (2022)

Emergence and Persistence of Letermovir-Resistant Cytomegalovirus in a Patient With Primary Immunodeficiency
por: Popping, Stephanie, et al.
Publicado: (2019)

Cutaneous parasitism in patients with American visceral leishmaniasis in an endemic area
por: Moura, Carla Riama Lopes de Pádua, et al.
Publicado: (2020)

1368. Stakeholders Perceptions on Barriers and Facilitators to Opt-Out Infectious Diseases Care in Jails
por: Smyth, Emma M, et al.
Publicado: (2022)

Proprotein Convertase Subtilisin/Kexin 9 Levels in Relation to Systemic Immune Activation and Subclinical Coronary Plaque in HIV
por: Zanni, Markella V, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lvicduekjmal8317nrq0sht9ge